Clinical Trial Update: Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating aprepitant to prevent postoperative nausea and vomiting in women undergoing elective hysterectomy was terminated; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• EMEND (aprepitant)

Snippet

Sponsor: Mayo Clinic | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: TERMINATED | Results posted: 2012-03-30